Service Provider Life Cycle Management - Essential Steps to Achieving Quality and Compliance
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More information
Directive 2001/83 |
The EU Clinical Trials Regulation |
EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines |
EMA Human Medicines | EU Information for Human Medicines |
Eudralex | EU Legislation for Medicinal Products |
Eudralex Pharma Section | EU Pharmaceuticals Information |
Eudralex Volume 1 - Legislation Human | EU Legislation for Human Medicinal Products |
Eudralex Volume 3 - Guidelines Human | EU Scientific Guidelines for Human Medicinal Products |
Eudralex Volume 4 - GMP Human and Veterinary | EU GMP Guidelines for Human and Veterinary Medicinal Products |
Good Distribution Practice | Guideline on Good Distribution Practice |
Mutual Recognition Agreements (MRAs) | Information on Mutual Recognition Agreements between EU and Non-EU Countries |
UK Medicines Act 1968 | UK Legislation on Medicines |
Licensing of Medicines | Information on Licensing of Medicines in the UK |
UK GMP | Information on UK GMP |
UK Guidance Notes | UK Guidance Notes for Medicines |
GMP Q&A | MHRA Frequently Asked Questions on GMP |
UK S2012/1916 | The Human Medicines Regulations 2012 |
CFRs | US Legislation on Food, Drugs and Cosmetics |
FDA Investigations Operation Manual | Guidance on FDA Inspections - General |
FDA Inspection Guides | Guidance on FDA Inspections - Specific Topics |
FDA CBER Guidance/Guidelines/Points to Consider | FDA Guidances and Regulatory Information for Biologics |
FDA CDER Guidances | FDA Guidances and Regulatory Information for Drug Products |
FDA Guidance for Industry - Sterile Drug Products Produced by Aseptic Processing Current GMP | US Guidance on Requirements for Aseptically Manufactured Drug and Biological Products |
Click here to view the process which covers planning, types of inspection, notification, conduct, definition of deficiencies, post-inspection letter, referal to Inspection Action Group, company responses and inspection report.